- Home
- Avandia
Avandia (rosiglitazone)
Relevant press releases
- 7 Feb 2011: GSK revises US Avandia label to include new restrictions on use
- 23 Sep 2010: GSK regulatory update on Avandia following EMA and FDA reviews
- More press releases
Information for patients
This information is intended for patients in Europe, the UK and the US. It includes links to further resources, guidance and advice..
Message from Dr Ellen Strahlman
Ellen Strahlman, Chief Medical Officer, talks about the efficacy and safety reviews made by regulatory authorities in Europe and the US and how this will affect patients.
Information for healthcare professionals
This information is intended for healthcare professionals in Europe and the US. It includes links to further resources.
Information for investors and the media
The information in the Avandia Resource Centre is intended for business journalists and analysts/investors. It includes news on Avandia and links to relevant press releases and statements.